Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S (+)-Ibuprofen for Acute Low Back Pain
NCT04772781Phase 2Completed
- Sponsor
- Apsen Farmacêutica
- Start
- Jun 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibuprofen in acute low back pain, sponsored by Apsen Farmacêutica. Started Jun 2022; status: completed.
02
Drugs
ibuprofen
03
Conditions
acute low back pain
Beyond the preview
Go deeper on NCT04772781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04772781.